Adaptive immunity selects against malaria infection blocking mutations

PLoS Comput Biol. 2020 Oct 8;16(10):e1008181. doi: 10.1371/journal.pcbi.1008181. eCollection 2020 Oct.

Abstract

The mutation responsible for Duffy negativity, which impedes Plasmodium vivax infection, has reached high frequencies in certain human populations. Conversely, mutations capable of blocking the more lethal P. falciparum have not succeeded in malarious zones. Here we present an evolutionary-epidemiological model of malaria which demonstrates that if adaptive immunity against the most virulent effects of malaria is gained rapidly by the host, mutations which prevent infection per se are unlikely to succeed. Our results (i) explain the rarity of strain-transcending P. falciparum infection blocking adaptations in humans; (ii) make the surprising prediction that mutations which block P. falciparum infection are most likely to be found in populations experiencing low or infrequent malaria transmission, and (iii) predict that immunity against some of the virulent effects of P. vivax malaria may be built up over the course of many infections.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptive Immunity / genetics*
  • Computational Biology
  • Evolution, Molecular
  • Genetic Predisposition to Disease / genetics*
  • Humans
  • Malaria, Falciparum / epidemiology
  • Malaria, Falciparum / genetics*
  • Malaria, Falciparum / immunology
  • Malaria, Vivax / epidemiology
  • Malaria, Vivax / genetics
  • Malaria, Vivax / immunology
  • Models, Genetic
  • Mutation / genetics*
  • Plasmodium falciparum / immunology
  • Plasmodium vivax / immunology

Grants and funding

Funding was provided to SG by the Leverhulme Trust (Visiting Profesorship VP2-2016-028) and by the Agence Nationale de la Recherche (ANR-17-CE35-0012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.